CUSIP 075887109COMBDXQ4 2025
50 reported transactions
| # | Date | Insider | Title | Type | Shares | Price | Value | Held After | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Jun 10, 2026 | Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | S · Sell | 1.1K | $151.48 | $166.6K | 14.3K | SEC |
| 2 | Jun 1, 2026 | Polen Thomas E Jr | Chairman, CEO and President | M · Option Exercise | 20.2K | $126.16 | $2.55M | 125.7K | SEC |
| 3 | Jun 1, 2026 | Polen Thomas E Jr | Chairman, CEO and President | D · Disposition | 17.4K |
See the full Form 4 transaction history for Becton Dickinson & Co.
Unlock all transactions| $146.15 |
| $2.55M |
| 108.2K |
| SEC |
| 4 | Jun 1, 2026 | Polen Thomas E Jr | Chairman, CEO and President | S · Sell | 2.8K | $146.35 | $404.5K | 110.2K | SEC |
| 5 | Jun 1, 2026 | Polen Thomas E Jr | Chairman, CEO and President | M · Option Exercise | 20.2K | $0.00 | $0 | 0 | SEC |
| 6 | Jun 1, 2026 | Menziuso Peter | EVP and President, BDI | A · Grant | 14.3K | $0.00 | $0 | 14.3K | SEC |
| 7 | May 26, 2026 | Feld Michael | EVP, Chief Revenue Officer | S · Sell | 75 | $147.35 | $11.1K | 21.1K | SEC |
| 8 | May 8, 2026 | Huffines Robert Luther | Director | A · Grant | 210 | $149.04 | $31.3K | 404 | SEC |
| 9 | May 8, 2026 | Byington Carrie L | Director | A · Grant | 105 | $149.04 | $15.6K | 3.7K | SEC |
| 10 | May 7, 2026 | Roque Vitor | EVP & Chief Financial Officer | A · Grant | 1.7K | $0.00 | $0 | 8.2K | SEC |